Cell fate determination during G1 phase progression

Cellular and Molecular Life Sciences

Volumn 64, Issue 23, 2007, Pages 3084-3104

  Blomen, V A ^a   Boonstra, J ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Institute of Biomembranes   (Netherlands)

Author keywords

Apoptosis; Cell cycle; Differentiation; G1 phase; Quiescence; Senescence

Indexed keywords

APOPTOSIS; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL FATE; CELL STIMULATION; DEPLETION; MOUSE; NONHUMAN; REVIEW; SENESCENCE; STRESS; TELOMERE;

EID: 38549161152     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7271-z     Document Type: Review

References (155)

1. Serrano, M. and Blasco, M. A. (2001) Putting the stress on senescence. Curr. Opin. Cell Biol. 13, 748-753.
2. Brill, A., Torchinsky, A., Carp, H. and Toder, V. (1999) The role of apoptosis in normal and abnormal embryonic development. J. Assist. Reprod. Genet. 16, 512-519.
3. Zetterberg, A., Larsson, O. and Wiman, K. G. (1995) What is the restriction point? Curr. Opin. Cell Biol. 7, 835-842.
4. Shih, H. H., Tevosian, S. G. and Yee, A. S. (1998) Regulation of differentiation by HBP1, a target of the retinoblastoma protein. Mol. Cell. Biol. 18, 4732-4743.
5. Hulleman, E., Bijvelt, J. J.M., Verkleij, A. J., Verrips, C. T. and Boonstra, J. (2004) Identification of a restriction point at the M/G1 transition in CHO cells. Cell. Mol. Life Sci. 61, 600-609.
6. Bird, R. C. (2003) Role of cyclins and cyclin-dependent kinases in G1 phase progression. In: G1 Phase Progression (Boonstra, J., Ed.), pp 40-68. New York, Kluwer.
7. Boonstra, J. (2003) Restriction points in the G1 phase of the mammalian cell cycle. In: G1 Phase Progression (Boonstra, J., Ed.), pp 1-13. New York, Kluwer.
8. Johnson, D. G., and Walker, C. L. (1999) Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 39, 295-312.
9. Shafer, K. A. (1998) The cell cycle: a review. Vet. Pathol. 35, 461-478.
10. Stevaux, O. and Dyson, N. J. (2002) A revised picture of the E2F transcriptional network and RB function. Curr. Opin. Cell Biol. 14, 684-691.
11. Sherr, C. J. and Roberts, J. M. (1999)CDKinhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512.
12. Stewart, Z. A. and Pietenpol, J. A. (2001) p53 signalling and cell cycle checkpoints. Chem. Res. Toxicol. 14, 243-263.
13. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. (1994) Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54, 3391-3395.
14. Itahana, K., Dimri, G. P., Hara, E., Itahana, Y., Zou, Y., Desprez, P-Y., and Campisi, J. (2002) A role for p53 in maintaining and establishing the quiescence growth arrest in human cells. J. Biol. Chem. 277, 18206-18214.
15. Yusuf, I. and Fruman, D. A. (2003) Regulation of quiescence in lymphocytes. Trends Immunol. 24, 380-386.
16. Coller, H. A., Sang, L. and Roberts, J. M. (2006) A new description of cellular quiescence. PLoS Biol. 4, 329-349.
17. Boonstra, J. (2003) Progression through the G1-phase of the on-going cell cycle. J. Cell Biochem. 90, 244-252.
18. Ladha, M. H., Lee, K. Y., Upton, T. M., Reed, M. F. and Ewen, M. E. (1998) Regulation of exit from quiescence by p27 and cyclin D1-CDK4. Mol. Cell. Biol. 18, 6605-6615.
19. Pajalunga, D., Mazzola, A., Salzano, A. M., Biferi, M. G., De Luca, G. and Crescenzi, M. (2007) Critical requirement for cell cycle inhibitors in sustaining nonproliferative states. J. Cell Biol. 176, 807-818.
20. Ezhevsky, S. A., Ho, A., Becker-Hapak, M., Davis, P. K. and Dowdy, S. F. (2001) Differential regulation of retinoblastoma tumor suppressor protein by G1 cyclin-dependent kinase complexes in vivo. Mol. Cell. Biol. 21, 4773-4787.
21. Mayol, X. and Grana, X. (1998) The p130 pocket protein: keeping order at cell cycle exit/re-entrance transitions. Front. Biosci. 3, 11-24.
22. Smith, E. J., Leone, G., DeGregori, J., Jakoi, L. and Nevins, J. R. (1996) The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol. Cell. Biol. 16, 6965-6976.
23. Vidal, A. and Koff, A. (2000) Cell-cycle inhibitors: three families united by a common cause. Gene 247, 1-15.
24. Digregori, J. and Johnson, D. G. (1996) Distinct and overlapping roles for E2F family members in transcription, proliferation, and apoptosis. Curr. Mol. Med. 6, 739-748.
25. Macaluso, M., Montanari, M. and Giordano, A. (2006) Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodelling enzymes. Oncogene 25, 5263-5267.
26. Zhu, L. and Skoultchi, A. (2001) Coordinating cell proliferation and differentiation. Curr. Opin. Genet. Dev. 10, 91-97.
27. Cobrinik, D. (2005) Pocket proteins and cell cycle control. Oncogene 24, 2796-2809.
28. Tedesco, D., Lukas, J., and Reed, S. I. (2002) The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSKP2. Genes Dev. 16, 2946-2957.
29. Sage, J., Miller, A. L., Perez-Macera, P. A., Wysocki, J. M. and Jacks, T. (2000) Targeted disruption of the three Rbrelated genes leads to loss of G1 control and immortalization. Genes Dev. 14, 3037-3050.
30. Sherr, C. J. and Roberts, J. M. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
31. KIP1 for restriction point control of the fibroblast cell cycle. Science 272, 877-880.
32. KIP1 by cDNA antisense suppresses quiescence (G0 State) in fibroblasts. J. Biol. Chem. 271, 18337-18341.
33. Bouchard, C., Thieke, K., Maier, A., Saffrich, R., Hanley-Hyde, J., Ansorge, W., Reed, S., Sicinski, P., Bartek, J. and Eilers, M. (1999) Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J. 18, 5321-5333.
34. (Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18, 1571-1583.
35. Tyner, A. L. and Gartel, A. L. (2003) Roles of cyclin kinase inhibitors in G1 phase progression. In: G1 Phase Progression (Boonstra, J., Ed.), pp 58-76. New York, Kluwer.
36. kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol. 17, 5348-5358.
37. Lee, H., and Kay, E. P. (2003) cAMP regulates cdk4 and p27 expression by inhibiting PI 3-kinase/Akt pathways in corneal endothelial cells. Invest. Opthalmol. Vis. Sci. 44, 3816-3825
38. Kip1 and Cdk4 in actively cycling and contact inhibited rabbit corneal endothelial cells. Mol. Vis. 7, 271-270.
39. Alessandrini, A., Chiaur, D. S. and Pagano, M. (1997) Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 11, 342-345.
40. cip1/waf1. Science 187, 1804-1808.
41. Nakanishi, M., Adami, G. R., Robertorye, R. S., Noda, A., Venable, S. F., Dimitrov, D., Pereira-Smith, O. M. and Smith, J. R. (1995) Exit from G0 and entry into the cell cycle of cells expressing p21 Sdi1 antisense RNA. Proc. Natl. Acad. Sci. USA 92; 4352-4356.
42. Kwon, Y. H., Jovanovic, A., Serfas, M. S., Kiyokawa, H. and Tyner, A. L. (2002) p21 functions to maintain quiescence of p27-deficient hepatocytes. J. Biol. Chem. 277, 41417-41422.
43. Denicourt, C. and Dowdy, S. F. (2004) Cip/Kip proteins:more than just CDK inhibitors. Genes Dev. 18, 851-855.
44. Lea, N. C., Orr, S. J., Stoeber, K., Williams, G. H., Lam, E. W.F., Ibrahim, M. A.A., Mufti, G. J. and Thomas, N. S.B. (2003) Commitment point during G0→G1 that controls entry into the cell cycle. Mol. Cell. Biol. 23, 2351-2361.
45. Furukawa, Y., Kikuchi, J., Nakamura, M., Iwase, S., Yamada, H. and Matsuda, M. (2000) Lineage-specific regulation of cell cycle control gene expression during haematopoietic cell differentiation. Br. J. Haematol. 110, 663-673.
46. Hulleman, E., Bijvelt, J. J.M., Verkleij, A. J., Verrips, C. T. and Boonstra, J. (1999) Integrin signaling at the M/G1 transition induces expression of cyclin E. Exp. Cell Res. 253, 422-431.
47. Obaya, A. J. and Sedivy, J. M. (2002) Regulation of cyclin-CDK activity in mammalian cells. Cell. Mol. Life Sci. 59, 126-142.
48. Zhu, X., Ohtsubo, M., Böhmer R. M., Roberts J. M., Assoian R. K. (1996) Adhesion-dependent cell cycle progression linked to the expression of cyclin Dl, activation of cyclin Ecdk2, and phosphorylation of the retinoblastoma protein. J. Cell. Biol. 133:391-403.
49. Schulze, A., Thome-Zerfass, K., Bergès, J., Middendorp, S., Jansen-Dörr, P., Henglein, B. (1996) Anchorage-dependent transcription of the cyclin A gene. Mol. Cell. Biol. 16, 4632-4638.
50. Schulze, A., Mannhardt, B., Zerfass-Thome, K., Zwerschke, W., and Jansen-Dürr, P. (1998) Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16. J. Virol. 72, 2323-2334
51. Kato, A., Takahashi, H., Takahashi, Y. and Matsushime, H. (1997) Inactivation of the cyclin D-dependent kinase in the rat fibroblast cell line, 3Y1, induced by contact inhibition. J. Biol. Chem. 272, 8065-8070.
52. kip1- mediated mechanism of contact inhibition in thyroid anaplastic carcinomas. Carcinogen. 26, 1021-1034.
53. KIP1. J. Cell Biol. 142, 557-571.
54. Stephani, U., Sutter, A. and Zimmermann, A. (1987) Nerve growth factor (NGF) in serum: evaluation of serum NGF levels with a sensitive bioassay employing embryonic sensory neurons. J. Neurosci. Res. 17, 25-35.
55. Carpenter, G. and Cohen, S. (1979) Epidermal growth factor. Annu. Rev. Biochem. 48, 193-216.
56. MAPKK) in fibroblasts. J. Cell Biol. 122, 1079-1088.
57. Hulleman, E. and Van Rossum, G. S.A. T. (2003) Regulation of the G1 phase progression by growth factors. In: G1 Phase Progression (Boonstra, J., Ed.), pp 93-109. New York, Kluwer.
58. MAPK during the ongoing cell cycle. J. Cell Physiol. 180, 325-333.
59. Brunet, A., Roux, D., Lenormand, P., Dowd, S., Keyse, S. and Pouysségur, J. (1999) Nuclear translocation of p21/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18, 664-674.
60. Krathwohl, M. D. and Kaiser, J. L. (2004) Chemokines promote quiescence and survival of human neural progenitor cells. Stem Cells 22:109-118.
61. Hulleman, E. and Boonstra, J. (2001) Regulation of G1 phase progression by growth factors and the extracellular matrix. Cell. Mol. Life Sci. 58, 80-93.
62. Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P. and Campisi, J. (2003) Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22, 4212-4222.
63. Smith, J. R. and Pereira-Smith, O. M. (1996) Replicative senescence: implications for in vivo aging and tumor suppression. Science 273, 63-67.
64. Cristofalo, V. J., Lorenzini, A., Allen, R. G., Torres, C. and Tresini, M. (2004) Replicative senescence: a critical review. Mech. Aging Dev. 125, 827-848.
65. Stein, G. H., Drullinger, L. F., Soulard, A. and Dulić, V. (1999) Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell. Biol. 19, 2109-2117.
66. Blagosklonny, M. V. (2006) Cell senescence: hypertropic arrest beyond the restriction point. J. Cell Physiol. 209, 592-597.
67. Bennett, D. C. and Medrano, E. E. (2002) Molecular regulation of melanocyte senescence. Pigment Cell Res. 15, 242-250.
68. Golubnitschaja, O. (2007) Cell cycle checkpoints: the role and evaluation for early diagnosis of senescence, cardiovascular, cancer, and neurodegenerative diseases. Amino Acids 32, 359-371.
69. (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA 93:13742-13747.
70. Wang, W., Martindale, J. L., Yang, X., Chrest, F. J. and Gorospe, M. (2005) Increased stability of the p16 mRNA with replicative senescence. EMBO Rep. 6, 158-164.
71. INK4a can initiate an autonomous senescence program. Oncogene 19:1613-1622.
72. Dulić, V., Beney, G-E., Febourg, G., Drullinger, L. F. and Stein, G. H. (2000) Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Mol. Cell. Biol. 20, 6741-6754.
73. Afshari, C. A., Nichols, M. A., Xiong, Y. and Mudryj, M. (1996) A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts. Cell Growth Differ. 7, 979-988.
74. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
75. Campisi, J. (2005) Senescent cells, tumor suppression, and organismal aging: good citizins, bad neighbors. Cell 120, 513-522.
76. Blagosklonny, M. V. (2003) Cell senescence and hypermitogenic arrest. EMBO Rep. 4, 358-362.
77. Lin, A. W., Barradas, M., Stone, J. C., Van Aelst, L., Serrano, S. and Lowe, S. W. (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic stimulation. Genes Dev. 12, 3008-3019.
78. INK4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA 92, 6289-6293.
79. Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G. and Bartek, J. (1995) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375, 503-506.
80. INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat. Cell Biol. 8, 1291-1297
81. Boonstra, J. and Post, J. A. (2004) Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 337, 1-13.
82. Macip, S., Igarashi, M., Fang, L., Chen, A., Pan, Z-Q., Lee, S. W. and Aaronson, S. A. (2002) Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. EMBO J. 21, 2180-2188.
83. Cip1/WAF1. Basic Res. Cardiol. 97, 117-124.
84. Chin, L., Pomerantz, J. and DePinho, R. A. (1998) The INK4a/Arf tumor suppressor: one gene-two products-two pathways. Trends Biochem. Sci. 23, 291-296.
85. ARF tumor suppressor. Mol. Cell. Biol. 20, 273-285.
86. INK4a in p53-independent telomere-directed senescence. Curr. Biol. 14, 2302-2308.
87. Chaturvedi, V., Cesnjaj, M., Bacon, P., Panella, J., Chouby, D., Diaz, M. O. and Nickoloff, B. J. (2003) Role of INK4a/Arf locus-encoded senescent checkpoints activated in normal and psoriatic keratinocytes. Am. J. Pathol. 162, 161-170.
88. INK4a. Mol. Cell 14, 501-513.
89. Helmbold, H., Deppert, W. and Bohn, W. (2006) Regulation of cellular senescence by Rb2/p130. Oncogene 25, 5257-5262.
90. Futreal, P. A. and Barrett, J. C. (1991) Failure of senescent cells to phosphorylate the Rb protein. Oncogene 6, 1109-1113.
91. Pignolo, R. J., Martin, B. G., Horton, J. H., Kalbach, A. N. and Cristofalo, V. J. (1998) The pathway of cell senescence: WI-38 cells arrest in late G1 and are unable to traverse the cell cycle from a true G0 state. Exp. Gerontol. 33, 67-80.
92. Bartek, J. and Lukas, J. (2001) Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr. Opin. Cell Biol. 13, 738-747.
93. Durand, B., Gao, F. B. and Raff, M. (1997) Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J. 16, 306-317.
94. KIP1 alters the response of cells to mitogens and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation. Curr. Biol. 8, 431-440.
95. KIP1 and inactivation of cdk2 kinase. Blood 96, 746-2754.
96. CIP1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep. 2, 27-34.
97. Tamir, A., Petrocelli, T., Stettler, K., Chu, W., Howard, J., St Croix, B., Slingerland, J. and Ben-David, Y. (2000) Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes: a role for p27 in erythroid differentiation coupled G1 arrest. Cell Growth Differ. 11, 269-277.
98. WAF1 is required for survival of differentiating neuroblastoma cells. Mol. Cell. Biol. 16, 1335-1341.
99. Muñoz-Alonso, M. J. and León, J. (2003) G1 phase control and cell differentiation. In: G1 Phase Progression (Boonstra, J., Ed.), pp 236-242. New York, Kluwer.
100. Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science 280, 1069-1072.
101. KIP1 is an inducer of intestinal epithelial cell differentiation. Am. J. Physiol. Cell Physiol. 279, c1045-c1057.
102. Coqueret, O. (2003) New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 13, 65-70.
103. INK4a in leukemic u-937 cells reveals dissociation between cell cycle and differentiation. Exp. Hematol. 29, 1382-1391.
104. INK4a is associated with, but not sufficient for, induction of squamous differentiation. J. Cell Sci. 111, 1185-1196.
105. Tang, X. M., Beesley, J. S., Grinspan, J. B., Seth, P., Kamholz, J. and Cambi, F. (1999) Cell cycle arrest induced by ectopic expression of p27 is not sufficient to promote oligodendrocyte differentiation. J. Cell Biochem . 76, 270-279.
106. (WAF1/Cip1) by STAT5. Mol. Cell. Biol. 17, 2933-2943.
107. WAF1 expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment. J. Biol. Chem. 273, 23517-23523.
108. Clegg, C. H., Linkhart, T. A., Olwin, B. B. and Hauschka, S. D. (1987) Growth factor control of skeletal muscle differentiation: committment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J. Cell Biol. 105, 949-956.
109. Lathrop, B., Thomas, K. and Glaser, L. (1985) Control of myogenic differentiation by fibroblast growth factor is mediated by position in the G1 phase of the cell cycle. J. Cell Biol. 101, 2194-2198.
110. Gao, C. Y. and Zelenka, P. S. (1997) Cyclins, cyclin-dependent kinases and differentiation. BioEssays 19, 307-315.
111. Wille, J. J. and Scott, R. E. (1982) Topography of the predifferentiation GD growth arrest state relative to other growth arrest states in the G1 phase of the cell cycle. J. Cell Physiol. 112, 115-122.
112. Scott, R. E., Florine, D. L., Wille, J. J. Jr and Yun, K. (1982) Coupling of growth arrest and differentiation at a distinct state in the G1 phase of the cell cycle: GD. Proc. Natl. Acad. Sci. USA 79, 845-849.
113. Kranenburg, O., Van der Eb, A. J., Zantema, A. (1995) Cyclin-dependent kinases and pRb: regulators of the proliferation-differentiation switch. FEBS Lett. 367, 103-106.
114. Herwig, S. and Strauss, M. (1997) The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur. J. Biochem. 245, 581-601.
115. Zhang, P. (1999) The cell cycle and development: redundant roles of cell cycle regulators. Curr. Opin. Cell Biol. 11, 655-662.
116. Lipinski, M. M. and Jacks, T. (1999) The retinoblastoma gene family in differentiation and development. Oncogene 18, 7873-7882.
117. Yee, A. S., Shih, H. H. and Tevosian, S. G. (1998) New perspectives on retinoblastoma family functions in differentation. Front. Biosci. 3, 532-547.
118. Thomas, D. M., Carty, S. A., Piscopo, D. M., Lee, J.-S., Wang, W.-F., Forrester, W. C. and Hinds, P. W. (2001) The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol. Cell 8, 303-316.
119. Harper, G. P. and Thoenen, H. (1980) Nerve growth factor: biological significance, measurement, and distribution. J. Neurochem. 34, 5-16.
120. Sofroniew, M. V., Howe, C. L. and Mobley, W. C. (2001) Nerve growth factor signalling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24, 1217-1281.
121. Varon, S. (1975) Nerve growth factor and its mode of action. Exp. Neurol. 48, 75-92.
122. Boonstra, J., Mummery, C. L., Feyen, A., De Hoog, W. J., Van der Saag, P. T. and De Laat, S. W. (1987) Epidermal growth factor receptor expression during morphological differentiation of pheochromocytoma cells, induced by nerve growth factor or dibutyryl cyclic AMP. J. Cell Physiol. 131, 409-417.
123. Vaudry, D., Stork, P. J.S. and Eiden, L. E. (2002) Signaling pathways for PC12 cell differentiation: making the right connections. Science 296, 1648-1649
124. Traverse, S., Gomez, N., Paterson, H., Marshall, C. and Cohen, P. (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288, 351-455.
125. WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor. J. Neurosci. 17, 6122-6132.
126. WAF1/CIP1 during NGF-mediated neuronal differentiation. Oncogene 18, 2872-2882.
127. Li, H. Z., Kawasaki, H., Nishida, E., Hattori, S., and Nakamura, S. (1996) Ras-regulated hypophosphorylation of the retinoblastoma protein mediates neuronal differentiation in PC12 cells. J. Neurochem. 66, 2287-2294.
128. Unsicker, K., Skaper, S. D. and Varon, S. (1985) Phenotypical changes of embryonic chick adrenal medullary cells in vitro induced by nerve growth factor and ciliary neurotrophic factor. Neurosci. Lett. 60, 127-132.
129. Young, J. and Yankner, B. A. (2000) Apoptosis in the nervous system. Nature 407, 802-809.
130. Hengartner, M. O. (2000) The biochemistry of apoptosis. Nature 407, 770-776.
131. Meier, P., Finch, A. and Evan, G. (2000) Apoptosis and development. Nature 407, 796-801.
132. Evan, G. I. and Vousden, K. H. (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342-348.
133. Yonish-Rouach, E. (1996) The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis. Experientia 52, 1001-1007.
134. Vermeulen, K., Berneman, Z. N. and Van Bockstaele, D. R. (2003) Cell cycle and apoptosis. Cell. Prolif. 36, 165-175.
135. Sherr, C. J. and Weber, J. D. (2000) The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10, 94-99.
136. Liemann, J. H., Worley, L. A. and Harbour, J. W. (2005) Loss of Rb-E2F repression results in caspase-8-mediated apoptosis through inactivation of focal adhesion kinase. J. Biol. Chem. 280, 10484-10490.
137. Liu, D. X. and Greene, L. A. (2001) Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res. 305, 217-228.
138. Müller, H., Bracken, A. P., Vernell, R., Cristina Moroni, M., Christians, F., Grassilli, E., Prosperini, E., Vigo, E., Oliner, J. D. and Helin, K. (2001) E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15, 267-285.
139. King, K. L. and Cidlowski, J. A. (1998) Cell cycle regulation and apoptosis. Annu. Rev. Physiol. 60, 601-617.
140. Pucci, B., Kasten, M. and Giordano, A. (2000) Cell cycle and apoptosis. Neoplasia 2, 291-299.
141. Kelley, L. L., Green, W. F., Hicks, G. G., Bondurant, M. C., Koury, M. J. and Ruley, H. U. (1994) Apoptosis in erythroid progenitors deprived of erythropoietin occurs during the G1 and S phases of the cell cycle without growth arrest or stabilization of wild-type p53. Mol. Cell. Biol. 14, 4183-4192.
142. Kastan, M. B., Canman, C. E. and Leonard, C. J. (1995) p53, cell cycle control and apoptosis: implications for cancer. Cancer Metast. Rev. 14, 3-15.
143. Oren, M. (2003) Decision making by p53: life, death, and cancer. Cell Death Differ. 10, 431-442.
144. Sõti, C., Sreedhar, S. A. and Csermeley, P. (2003) Apoptosis, necrosis and cellular senescence: chaperone occupancy as a potential switch. Aging Cell 2, 39-45.
145. Rebbaa, A., Zheng, X., Chou, P. M. and Mirkin, B. L. (2003) Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene 22, 2805-2811.
146. Barres, B. A., Hart, I. K., Coles, H. S.R., Burne, J. F., Voyvodic, J. T., Richardson, W. D. and Raff, M. C. (1992) Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70, 31-47.
147. Thomaidu, D., Mione, M. C., Cavanagh, J. F.R. and Parnavelas, J. G. (1997) Apoptosis and its relation to the cell cycle in the developing cerebral cortex. J. Neurosci. 17, 1075-1085.
148. Van Opstal, A. and Boonstra, J. (2006) Inhibitors of phosphatidylinositol 3-kinase activity prevent cell cycle progression and induce apoptosis at the M/G1 transition in CHO cells. Cell. Mol. Life Sci. 63, 220-228.
149. Li, M., Hu, J., Hermeier, K., Henninghausen, L., and Furth, P. A. (1996) Expression of a viral oncogene during mammary gland development alters cell fate and function: induction of p53-independent apoptosis is followed by impaired milk production in surviving cells. Cell. Growth Differ. 7, 3-11
150. Jerry, D. J., Dickinson, E. S., Roberts, A. L. and Said, T. K. (2002) Regulation of apoptosis during mammary involution by the p53 tumor suppressor gene. J. Dairy Sci. 85, 1103-1110.
151. Tiainen, M., Pajalunga, D., Ferrantelli, F., Soddu, S., Salvatori, G., Sacchi, A. and Crescenzi, M. (1996) Terminally differentiated skeletal myotubes are not confined to G0 but can reenter G1 upon growth factor stimulation. Cell. Growth Differ. 7, 1039-1050.
152. Miyauchi, H., Minamino, T., Tateno, K., Kunieda, T., Toko, H. and Komuro, I. (2004) Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 23, 212-220.
153. Takai, H., Smogorzewska, A. and de Lange, T. (2003) DNA damage foci at dysfunctional telomeres. Curr. Biol. 13, 1549-1556.
154. Thannickal, V. J., Day, R. M., Klinz, S. G., Bastien, M. C., Larios, J. M. and Fanburg, B. L. (2000) Ras-dependent and - independent regulation of reactive oxygen species by mitogenic growth factors and TGF-b1. FASEB J. 14, 1741-1748.
155. Hall, B. K. and Enayake, S. (1991) Effects of growth factors on the differentiation of neural crest cells and neural crest cell-derivatives. Int. J. Dev. Biol. 35, 367-387.